Neurology News

 
 
  • FDA Moves to Curb Misuse of ADHD Meds The FDA has announced updates to ADHD stimulant medication labels to note the serious risks of misuse, abuse, addiction, and the sharing of these drugs.
  • Common Gut Bacteria Linked to Parkinson's Disease Desulfovibrio, a common gut bacteria, may play a role in the development of Parkinson's disease by causing aggregation of the alpha-synuclein protein.
  • CGM Completes Picture of A1c in Type 2 Diabetes 'It is hoped that the use of these new [CGM] metrics should lead to an improved quality of glycemic control and, in turn, to a reduction in the number of diabetes-related complications,' say researchers.
  • Alert FDA Approves First Drug to Treat Alzheimer's Agitation The antipsychotic brexpiprazole (Rexulti) is the first FDA-approved treatment option for agitation associated with Alzheimer's disease.
  • AANS 2023 1 in 5 Brain Injury Trials Show Errors, Signs of Spin Researchers examined 150 randomized traumatic brain injury studies from 1960 to 2020 in top neurosurgery medical journals and found that 21% of them had mathematical errors or exaggerated results.
  • Alert FDA OKs New Drug for Fabry Disease Pegunigalsidase alfa (Elfabrio) is an intravenously administered enzyme replacement therapy to treat adults with confirmed Fabry disease.
  • CDC Cuts Back Hospital Data Reporting on COVID Some experts wonder whether CDC will have enough timely information to guide public health decisions if the virus comes roaring back.
  • Simplifying Diagnosis of Rejection After Kidney Transplant User-friendly ChatGPT-like system allows for accurate diagnoses of rejection, using often complicated Banff classification criteria 'with just a few clicks.' Observers hail the work as 'innovative.'
  • Deep Sleep May Mitigate the Impact of Alzheimer's Pathology Deep sleep may help protect cognitive reserve, acting as a buffer against Alzheimer's disease pathology.
  • Rheumatoid Arthritis Linked to Increased Parkinson's Risk A large prospective study shows that RA is linked to a twofold increased risk for Parkinson's disease, in new findings that suggest motor symptoms in this population should be thoroughly investigated by a neurologist.
  • Risk Assessment First Urged for Fragility Fracture Screening A new Canadian guideline recommends a risk assessment–first approach to fragility fracture screening before a bone mineral density test to facilitate shared decision-making.
  • AANS 2023 Clot Evacuation After ICH Tied to Better Outcome: ENRICH ENRICH trial results comparing minimally invasive trans-sulcal parafascicular surgery (MIPS) to standard care are encouraging but need replication in a larger trial, one outside expert says.
  • Feds Extend Pandemic Telehealth Rules Until November Restrictions on telehealth prescribing of controlled medications were set to resume May 11 with the end of the federal public health emergency. That's been postponed amid pushback from clinicians who want the more flexible pandemic rules to continue.
  • Cell Phone Use Linked to Hypertension Risk? A study hints that using a mobile phone may raise the risk of developing hypertension, but both researchers and outside experts urge caution in interpreting the results.
  • No Reliable Evidence Antidepressants Help Chronic Pain A major new review finds no reliable evidence that antidepressants help chronic pain, results of a new Cochrane review show.
  • Behavioral Therapy Reduces Long COVID Fatigue: Study People with long COVID reduced their fatigue after completing 17 weeks of cognitive behavioral therapy, compared with people with similar long COVID fatigue levels who didn't participate in therapy.
  • AACE 2023 New Protocol Cuts Fasting Time to Rule Out Insulinoma Stopping the fast prior to 72 hours resulted in hospital cost savings for patients with hypoglycemia in whom doctors used a new test to rule out an insulinoma, a rare pancreatic tumor.
  • Alert FDA Expands Use of Dapagliflozin to Broader Range of HF The SGLT2 inhibitor is now indicated for treatment of heart failure across the full spectrum of left-ventricular ejection fraction ― including HF with mildly reduced and preserved ejection fraction.
  • Part-Time Physician: Is It a Viable Career Choice? There may be many solutions for overstressed, burned out, and overworked physicians. Perhaps going part-time is one of them; but there are also negatives to consider.
  • Metformin Ups Myocardial Perfusion and Survival in T2D Treatment of adults with type 2 diabetes with metformin significantly linked with better myocardial perfusion and improved survival in a multicenter, observational study with 572 subjects.